Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis
Open Access
- 1 September 1999
- Vol. 116 (3) , 775-788
- https://doi.org/10.1378/chest.116.3.775
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Why Do Medical Nebulizers Differ in Their Output and Particle Size Characteristics?Journal of Aerosol Medicine, 1994
- Generation of Aerosolized DrugsJournal of Aerosol Medicine, 1994
- Aerosol antibiotic treatment in cystic fibrosis.Archives of Disease in Childhood, 1993
- Histologic changes in the respiratory tract induced by inhalation of xenobiotics: Physiologic adaptation or toxicity?Toxicology and Applied Pharmacology, 1989
- Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosisThe Journal of Pediatrics, 1988
- A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosisRespiratory Medicine, 1987
- Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosaRespiratory Medicine, 1987
- Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosisThe Journal of Pediatrics, 1987
- Antibiotic prophylaxis in cystic fibrosis: Inhaled cephaloridine as an adjunct to oral cloxacillinThe Journal of Pediatrics, 1982
- A therapeutic regimen for patients with cystic fibrosisThe Journal of Pediatrics, 1964